Defending against dangerous AI should be a national priority — and we need more AI to do it
A rogue state or terrorist organization has little reason to observe an AI slowdown. Source：MarketWatch
Quantum stocks are getting hot again after a brutal summer. Can the rally last?
This week’s Quantum World Congress could trigger a ‘sentiment reversal’ for quantum stocks after a rough summer, an analyst said. Source：MarketWatch
Canada's 'Big Six' banks to launch interbank tokenized deposit initiative
Initial testing will focus on moving digital commercial deposits across participating institutions before linking to broader digital asset ecosystems.…
How to avoid the ‘widow tax’ and other financial headaches if your spouse dies
A surviving spouse is sometimes left with less income and a higher tax bill. These taxsaving strategies can soften the impact. Source：MarketWatch
Want to retire with more money? Leave the country for work early in your career.
Gain experiences, memories and a substantial contribution to your future nest egg. Source：MarketWatch
Could Meta’s viral Muse app be the company’s ChatGPT moment?
Meta’s new assistant is topping App Store charts and beating ChatGPT’s early download pace, spurring renewed confidence in the company’s AI strategy…
Bitcoin price seeks $86K as new support after oil dips below $90
Bitcoin price action avoided a significant drop below $86,000 as US president Donald Trump pledged a deal with Iran after November’s midterm election.…
CLARITY vote failure could stoke more crypto PAC spending in key races
Control of the US House and Senate is up for grabs in 2026, and some advocates speculate that the crypto industry could ratchet up attempts to sway elections…
Sandisk’s stock is rising: Why one analyst says AI could help it reach new heights
Larger AI models and inference are turning NAND from a commodity into a critical component, a Rosenblatt analyst said. Source：MarketWatch
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
Viking Therapeutics is developing VK2735, a GLP1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring. Source：MarketWatch
Tax-free bond yields are in a sweet spot. Get in before it’s too late.
Yields on municipal bonds — adjusted for taxableequivalent comparisons — have widened dramatically over those of corporate bonds over the past two months.…
Next for the U.S. SEC: Agency's chief crypto counsel illuminates path for custody
Taylor Lindman, the top lawyer on the agency's Crypto Task Force, says the SEC is trying to get firms comfortable with blockchain technology and crypto assets.…